France's National Assembly will give final approval to assisted-dying bill after years of debate

France’s National Assembly is set to give final approval to a controversial assisted-dying bill after years of intense public and political debate. The lower house of parliament will vote on Wednesday to endorse the legislation, which permits adults with incurable illnesses to receive lethal medication under strict conditions. This marks the culmination of a long legislative process initiated by French President Emmanuel Macron more than three years ago. The bill, which was previously passed in three earlier readings, aims to provide legally sanctioned medically assisted suicide for specific groups. Under the proposal, patients must be at least 18 years old and either French citizens or legal residents. They must suffer from a serious, incurable illness that is life-threatening, experience unrelenting pain that cannot be alleviated, and make a voluntary request for lethal medication. Psychological suffering alone is not sufficient grounds for eligibility, and individuals with severe psychiatric disorders or neurodegenerative diseases such as Alzheimer’s are excluded. To qualify, patients must submit a request to a team of healthcare professionals, who will assess the situation and confirm the diagnosis. The process includes a mandatory waiting period of at least two days for the patient to reflect on their decision. Once approved, the patient can take the medication at their chosen location, either at home or in a healthcare facility, with the presence of family members if desired. On the day of the procedure, a doctor or nurse must verify the patient’s intent and stay close by to address any unforeseen complications. The law also ensures that all associated costs will be covered by France’s national health insurance system, removing financial barriers for those who might otherwise struggle to access the service. The bill explicitly prohibits euthanasia, distinguishing it from medically assisted suicide, which requires the patient to self-administer the medication. France’s aging population and rising prevalence of chronic illnesses have intensified calls for reform in end-of-life care. Traditionally a Catholic nation, France has faced complex ethical and religious debates surrounding the issue. Existing laws allow doctors to sedate terminally ill patients before death but do not permit active assistance in ending life. Many French citizens have turned to neighboring countries where assisted dying is legal, highlighting the demand for change. Support for the legislation appears widespread among the general public. A 2023 report indicated that most French people back legalizing end-of-life options, with support growing steadily over the past two decades. Advocacy groups, such as the Association for the Right to Die With Dignity, argue that the law respects individual autonomy and ensures that personal choices regarding medical treatment are honored. Their representative, Jonathan Denis, emphasized that the law guarantees the right to choose, without compelling anyone to act upon it. Opposition to the bill has been vocal, particularly from conservative and religious groups who fear the measure could lead to unintended consequences. Critics warn that the law might inadvertently expand access beyond its intended scope, potentially affecting vulnerable populations. Some lawmakers have raised concerns about the potential for abuse or misinterpretation of the criteria. As the National Assembly prepares to cast its final vote, the legislation represents a significant shift in France’s approach to end-of-life care. If passed, it will join a growing number of nations that have legalized forms of assisted dying, reflecting broader global trends toward greater acceptance of palliative care and patient autonomy. The outcome of this vote will shape future discussions on ethics, medicine, and human rights in France and beyond.